Fig. 4From: CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trialSubgroup analysis for complete response at end of treatment. LDH = lactate dehydrogenase, IPI = International Prognostic Index. *PTCL subtype includes PTCL-NOS and other typesBack to article page